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“The world as we have created it is a process 
of our thinking. It cannot be changed  
without changing our thinking.” 
 
Albert Einstein 
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Abstract 
The aim of this thesis was to explore sex differences in health care utilisation 
and costs (i) in a region in Sweden, (ii) in treatment of dialysis patients across 
the region, and (iii) in the treatment of specified dermatological diagnoses at 
an outpatient specialist clinic. Data were retrieved from medical records and 
health care and pharmaceutical databases, including cost estimates and survey 
data, and were analysed stratified by sex. The results showed that total per 
capita cost for health care was 20 per cent higher for women than for men. 
When total health care consumption was adjusted for reproduction and costs 
associated with sex-specific morbidity the cost difference declined to 8 per 
cent. The remaining cost difference could be explained by women’s 
substantially higher costs for mental health problems and diseases of the 
muscles and joints. Women were more likely to receive less expensive primary 
care, while men were more likely to receive specialist care. No differences in 
health-care-related dialysis costs were found between women and men, but the 
health-care-related costs of patients on in-centre dialysis were more than twice 
as high as those of patients on home dialysis. Men were more than three times 
more likely to receive home dialysis if they lived with a spouse compared to if 
they lived alone – an association that was not found among women. 
Additionally, patients had a higher likelihood of having home dialysis if they 
received pre-dialysis information from more sources and if the information 
was perceived as comprehensive and of high quality. The treatment for eczema 
and psoriasis demonstrated substantially greater cost for men, whilst women 
were more inclined to self-care in their home. In conclusion, to ensure the 
provision of gender equal and equitable health care services, it is important to 
disaggregate and analyse public health care spending by gender, including the 
impact of unpaid care work.  
Keywords: Sex, gender, health care economics and organisations, health care 
costs, dialysis, eczema, psoriasis, Sweden  
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Sammanfattning på svenska  
 
Syftet med denna avhandling har varit att undersöka kvinnors och mäns hälso- och 
sjukvårdsanvändning från ett kostnadsperspektiv på en (i) övergripande 
regional nivå, (ii) avseende behandling av samtliga dialyspatienter inom en 
region och (iii) behandlingen av patienter med eksem och psoriasis på en öppen 
specialistmottagning. Resultaten visar att kvinnor totalt konsumerar 20 procent 
mer sjukvård jämfört med män. Hälften av dessa merkostnader kan härledas till 
sjukvårdskostnader i samband med reproduktionen, huvudsakligen förlossnings-
relaterat. En ytterligare del förklaras av könsskillnader vid sjukvård i samband med 
könsspecifika sjukdomar, exempelvis bröst-, livmoderhals- och prostata-
cancer. Resterande skillnad förklaras av att kvinnor i högre utsträckning än 
män konsumerar sjukvård vid psykisk ohälsa och vid sjukdom i muskler och leder.  
Resultaten visar också att kvinnor i högre utsträckning får vård inom den 
mindre kostsamma primärvården medan män får mer vård inom 
specialistvården. Vid dialysbehandling fanns inga skillnader i sjukvårds-
relaterade kostnader utifrån ett könsperspektiv. Däremot var dialys på sjukhus 
mer än dubbelt så dyr jämfört med hemdialys. Det fanns inga skillnader i den 
totala hälsorelaterade livskvalitén mellan kvinnor och män, eller mellan 
patienter med hemdialys och sjukhusdialys.  
Resultaten visade en tre gånger högre sannolikhet för hemdialys bland män 
som bodde tillsammans med en partner jämfört med män som bodde ensamma. 
Ett sådant samband sågs inte hos kvinnor. Dessutom visade data att patienter 
som innan dialysstart fått information från fler källor och som uppfattat att 
informationen var omfattande och av god kvalitet, hade högre sannolikhet att 
välja hemdialys. Långa avstånd till dialysmottagning betydde också att det var 
mer troligt att valet föll på hemdialys.  
Män med eksem och psoriasis hade tydligt fler behandlingar och högre 
kostnader jämfört med kvinnor, samtidigt som kvinnor i högre utsträckning 
hade egenvård, det vill säga behandlade sig själva i hemmet med krämer och 
mjukgörare.  
De samlade resultaten visar att det är viktigt att fortsätta att analysera 
sjukvårdens behandlingar och behandlingskostnader utifrån ett köns- och 
genusperspektiv, och att i detta även inkludera den obetalda vårdens fördelning 
för att säkerställa tillgång till hälso- och sjukvård på ett jämställt och rättvist 
sätt – och i enlighet med de etiska principerna i svensk sjukvårdslagstiftning. 
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vi 
Useful definitions 
 
How “sex” and 
“gender” are 
used in this 
thesis 
The word “sex” is used in relation to statistics and the 
biological sex. The word “gender” is used when the social 
and cultural meanings of “sex” are discussed but also when 
the significance of sex and gender is mentioned on a more 
general level. 
Sex and gender The concepts of “sex” and “gender” are commonly used to 
refer respectively to the biological and the sociocultural 
aspects of being a man or a woman [1]. Chromosomes and 
external sexual characteristics define the biological sex and 
assign the legally demarcated binary sex (which constitutes 
the basis of sex-disaggregated statistics). Gender comprises 
the construction of “sex” and the relationship between 
women and men in the social structures of power and 
hierarchies and is changeable over time and location [2]. 
The gender 
system 
Gender and the gender system signify a societal structure  
that organises human activities and relations based on sex. 
Although gender studies cover a versatile and growing scope 
of theory and research, and opinions about gender and the 
gender system differ, a considerable consensus has been 
reached in two respects [3]. First, gender implies structures 
that help to keep apart women’s and men’s work, 
characteristics and behaviours; that is, a dichotomy [4]. The 
dichotomy manifests itself in ways such as the division of 
labour; for example, the fact that workers in the military and 
building trade are predominantly men and women do most 
paid and unpaid care for children and elderly [5]. The gender 
dichotomy also implies that human identity is formed by 
collective opinions about what is appropriate for women and 
men, respectively [6] e.g. by gender norms. Second, the 
relationship between the sexes is unequally divided in a male 
superiority and a female subordination; that is, asymmetry 
[4].  
Intersectionality Gender and the gender system intersect with other axes of 
inequality, such as age, socioeconomic position and ethnicity 
[7, 8]. Intersecting stratification processes can significantly 
vii 
alter the impact of gender by other dimensions of inequality 
operating simultaneously in society. The Swedish 
discrimination legislation include seven discrimination 
criteria; gender, age, ethnicity, sexual orientation, religion or 
other beliefs, gender identity or expression and disability. 
Gender dysphoria Gender dysphoria denotes distress caused by a discrepancy 
between the gender identity and a person’s sex assigned at 
birth. The condition is rare but increasing worldwide. 
Approximately 0.01 per cent of the total Swedish population 
had health care contact due to this condition in 2013 [9]. The 
number of individuals who have changed their legal sex and 
undergone a sex confirmatory medical treatment between 
1960 and 2011 was approximately 0.009 per cent of the total 
Swedish population [10]. Despite the low prevalence of the 
condition, implications for optimal medical treatment should 
be considered.  
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Introduction 
 
A fundamental objective for governments in many countries is to reduce 
inequality in the population, mainly through reallocation of resources through 
taxation, public spending and regulations [11].  
Recent decades have seen a rising interest and demand for investigations and 
analyses of how public resources are distributed between women and men and 
how they support and interact with the needs, conditions and preferences of 
women and men [12]. In Sweden, where a tax-funded health care system covers 
the entire population, health care constitutes a large and important part of public 
spending, corresponding to 14 per cent of total public expenses [13]. The annual 
cost of the Swedish health care sector amounted to 500 billion SEK (»50 billion 
Euros) in 2016. 
Differences between women’s and men’s health care utilisation have become 
increasingly evident [14] but remain a rather complex issue. First, a question 
that is largely still unresolved is how these differences manifest themselves, 
for example, in and between different treatments, diagnostic areas and health 
care sectors [15]. Second, what are the underlying causes behind the existing 
differences, and are they medically motivated? A third question relates to what 
the differences really imply regarding, for example, outcomes and resource 
allocation.  
There are many potential explanations for why health care utilisation differs 
between women and men. To put the studies in this thesis in a wider context, 
the health care service utilisation approach presented by Liss (1990) [16] (see 
Fig. 1.) can be employed as a conceptual basis of explanation. This approach 
can help clarify the theoretical distinction between women and men’s health 
care needs and demands, as well as the role of the health care provider’s 
recommendations; that is, the supply side.  
Another important issue is what distribution and outcome can be considered 
just and fair; that is, what do gender equality and equity really mean in the 
context of a publicly funded health care system? Additionally, because the 
health care system operates within the boundaries of limited resources, it is 
important to use the available health care resources in a way that balances 
efficiency against other priorities.  
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Figure 1. The health care service utilisation approach (Liss, 1990) [16] 
Despite the fact that the health care sector consumes a large amount of public 
resources and the large extent of health care service research, differences 
between women’s and men’s health care utilisation from a cost perspective 
remains largely unexplored, both at an aggregated level and within specific 
medical specialties. 
This thesis explores sex differences in total health care utilisation and costs in 
a region in Sweden, the treatment of a specific condition across the region and 
the treatment of specified diagnoses at an outpatient specialist clinic.  
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Background 
 
Public spending in the health care sector from  
a gender perspective 
The approach to disaggregating and analysing public spending by gender was 
advocated by the United Nations (UN) Fourth World Conference on Women 
held in Beijing in 1995, and emphasised in several paragraphs in the resulting 
document Platform for Action [17]. This approach has gained considerable 
attention among international organisations and governments, as well as within 
research [12, 18-26], and is often referred to as “gender budgeting” or “gender-
responsive budgeting”. The overall intention is to “follow the money” and to 
see how governments raise and spend money – who pays and who benefits, 
and whether it is equitable. Apart from promoting a more equitable resource 
allocation, gender-responsive budgeting analyses are considered to lead to 
efficiency gains in policy making and public spending and to enable 
accountability and transparency of the public economy [27].  
An early advocate of gender budgeting was Diane Elson (1992, 1995) [28, 29], 
who was involved in the development of the gender budgeting approach. She 
highlighted the relationship between public expenditures, e.g. public services, 
and unpaid care work i.e. informal care. Elson showed that when public 
services were cut back, females had to bear the bulk of the burden because of 
an increase in the unpaid care work in the home, replacing the reduced public 
services. Likewise, the time that women had available for market work was 
reduced, resulting in a private income loss and a loss in productivity in the 
society as a whole. Therefore, the gender budgeting approach suggests that 
value should be attached to time spent in the informal care economy and that 
this information should be used in assessing the benefits and costs of 
governments and other public programmes and spending [27]. This approach 
is also clearly traceable to the UN’s agenda for women’s empowerment, 
Platform for Action, mentioned above.  
Around 80 countries have started to analyse public income and expenditures 
from a gender perspective [25]. Analyses have been made with different 
approaches and in different areas, such as within the educational sector and in 
relation to the labour market. 
However, few studies have disaggregated and analysed public health care 
spending by gender. The demand for such analyses was pointed out back in 
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2002, when the National Board of Health and Welfare in Sweden reviewed and 
analysed gender equity trends in health care [14]. Their findings resulted in a 
strategy to make health care services more gender-sensitive, including a call to 
distinguish statistics and data – on activities, treatment outcomes and resource 
allocation – between females and males. World Health Organization (WHO) 
Europe recently advocated gender budgeting in the health care sector in order 
to strengthen women’s and men’s health, presented in the context of achieving 
the UNs sustainable development goals (SDGs) [30, 31]. The focus of this 
strategy is mainly on SDG3; good health and well-being, SDG5; gender 
equality and SDG10; reduced inequalities. Gender budgeting is advocated as a 
priority action to strengthen governance for women’s and men’s health (with 
reference to SDG16: peace, justice and strong institutions): 
 “Integrating gender budgeting across health policies and 
programmes for more efficient financing of the health priorities for 
both men and women and for promoting gender equality.” [31]  
 
Health care needs, demand and supply 
Health care demand in a publicly funded health service organisation is mainly 
a consequence of patients’ health care needs, how these needs are perceived 
and barriers to seeking health care [32, 33]. The degree to which demand leads 
to health care utilisation also depends on priorities set by the health care 
provider; that is, which health care services are provided, prevailing evidence-
based clinical guidelines, and the extent to which health care professionals 
identify needs and treatments accordingly. Political priorities and systemic and 
structural factors, etc. in the health care sector and in society at large are also 
influencing health care utilisation [32, 33]. In all these overlapping fields, sex 
and gender are assumed to play an important role. Figure 1 illustrates the health 
care service utilisation approach, and the three basic concepts of need, demand 
and the health care provider’s recommendation; that is, the supply side.  
Starting with the need dimension, it is well documented that there are a variety 
of “social determinants of health”, which refer to the general conditions in 
which people live and work, which influences their ability to live healthy lives. 
The social determinants of health are often described by a model [34-36] in 
which different layers of influence act together to generate the health of people 
and populations. Individual factors, which are at the centre of the model, 
include age, sex and congenital conditions. The next level corresponds to 
individual behaviour and lifestyle and includes eating, drinking and physical 
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exercise habits. The third level includes social and community influences such 
as friends’ and relatives’ provision (or non-provision) of support. An additional 
level includes individuals’ living and working conditions and access to 
essential goods and services such as education and health care services. Lastly, 
there is an over-arching structural level that includes the political, economic, 
cultural and environmental conditions prevalent in society as a whole.  
Gender and sex have been identified as major determinants of health, and 
hence, health care needs [37, 38]. Biological sex is at the core of the model. 
The gender system, however, is localised in the cultural sphere in the outermost 
layer where it overrides and influence all the other layers. 
Differences in women and men’s biological conditions result in different 
health care needs. Salient examples are needs connected to the asymmetric 
biological burden of reproduction, but also other clear sex-specific conditions. 
Other conditions are less well understood and are to some degree linked to 
biological differences and morbidity risks, such as differences in life 
expectancy, cardiovascular disease and osteoporosis [3, 39-41]. 
In addition, gender norms, socialisation patterns and structures in the family, 
in the labour market and in the public domain lead to differences in the disease 
spectrum [15, 42, 43]. Compared to men, women generally have lower status, 
less influence [44], lower salaries and greater stress levels in the workplace 
[45-48] and perform most of the unpaid work in the home [42, 49-52]. Women 
are also overrepresented in occupations in the health sector and social care that 
tear on muscles and joints [53, 54], and have greater exposure to intimate 
partner violence [55, 56]. Men are exposed to more accidents, including fatal 
accidents in the work place, exhibit greater risk behaviours (in relation to 
alcohol and violence, for example) and commit suicide more often [31]. 
Moreover, studies show that cultural gender norms form barriers preventing 
men from seeking health care to the same extent as women since they imply 
that weakness and need for help are not masculine traits [57-60]. In addition, 
Swedish data show that men consume more avoidable hospitalisations 
compared to women, i.e. avoidable if they had received adequate outpatient 
care [61]. Obviously, the gendered patterns affecting women’s and men’s 
health may vary in relation to other axes of inequality, such as age and 
socioeconomic position [62]. 
Nevertheless, the biological and social conditions that affect female and male 
health are not entirely separate variables; rather, they interact in the formation 
of health and illness in women and men [63, 64].  
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Hence, the sex and gender aspects of the social determinants of health are 
supposed to have a profound impact on women’s and men’s needs and 
subsequent demands for health care [37, 38], referring to areas 1 and 2 in 
Figure 1. The health care sector, also included in the social determinants of 
health, is discussed separately (vide infra). 
Another reason for sex differences in health care utilisation, being more at the 
supply side, is insufficient awareness of gender norms among health care 
personnel. Evidence suggests that women and men sometimes receive 
medically unmotivated treatment differences [2, 14, 65-70] and that men 
occasionally receive more resource-demanding treatment than women, even 
when the illness is the same [71, 72]. Research shows that gender plays an 
important but not necessarily appropriate role in medical decision making [65]. 
However, insufficient awareness regarding conditions requiring sex-specific 
differences in treatment to reach optimal outcome has also been noted [43, 73-
75]. 
Health care utilisation 
On the aggregated level, there is ample evidence indicating that several patient 
characteristics influence health care utilisation, the most important being 
patient age [76, 77]. However, factors such as sex, socioeconomic status, 
ethnicity and immigration status also influence individual health care 
consumption [76-80]. Several studies from high- and middle-income countries 
have demonstrated the effects of sex on health care consumption [76-83]. The 
results suggest that women generally consume more health care resources, 
especially primary care, than men. One reason for this difference is the 
prevalence of conditions related to reproduction; such conditions are 
predominant among women undergoing pregnancy and childbirth.  
One tool that can be used to better understand the demand for health care is the 
Grossman model [84]. In this model, health is viewed as a capital good that is 
depreciated over time. Individuals demand health (not health care), since they 
want to feel good and because it increases their number of healthy days 
available for work and leisure time. However, to make investments in health, 
individuals have to spend time and money on health-improving efforts, 
including health care visits. The model therefore predicts that individuals’ 
investments in health during an earlier life-cycle stage lowers or postpones 
subsequent morbidity. This should be reflected in less time per year in hospital 
for groups that received more (preventive) health care services in previous 
years, everything else equal. 
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Equality, equity and cost-effectiveness – the case of Sweden 
Governments and international organisations such as the World Health 
Organisation often propose the objective of reducing inequalities. In Sweden, 
the opening paragraph in the Swedish health and Medical Services Act (Law 
1997:142) is based on an equality and equity foundation (see below). The 
ethical platform for health care priority-setting [85, 86], which describes the 
intention of the law in more detail, has become a central guiding principle for 
the Swedish health care sector. The ethical platform comprises three principles 
that are explicitly ranked, with the first taking precedence over the second, and 
the second taking precedence over the third. The first is the human value 
principle, which states that all human beings are of equal value and have the 
same rights regardless of their personal characteristics or function in society 
(refers to non-discrimination in the health care sector). The second is the need 
and solidarity principle, which states that resources should be distributed 
according to need. If prioritisation is necessary, resources should be given to 
those people in greater need (that is, those with the most severe condition and 
those with the lowest quality of life). Third is the cost-effectiveness principle; 
that is, if a choice is to be made between different interventions, a reasonable 
relationship between costs and effects (measured in terms of improved health 
and quality of life) is to be achieved. 
The relationship between the need and solidarity principle and the cost-
effectiveness principle is such that patients with severe diseases and 
substantially impaired quality of life should take precedence over those with 
milder cases, even if this health care involves “substantially” greater costs for 
a given health benefit. 
The first principle in the ethical platform refers to non-discrimination (an 
equality concept), while the second refers to need and solidarity (an equity 
concept). Hence, it is important to investigate what these concepts mean in 
terms of sex and gender in the health care context.  
2 § The goal of the health care system is good health and care 
on equal terms for the entire population. The care should be 
provided with respect for the equal worth of all people and the 
dignity of the individual person. Those who have the greatest 
need for health care should be given priority. (Law 1997:142) 
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Gender equality and equity in health and health care  
Debates about gender justice are common in public policy in general and in the 
health care sector in particular and the terms gender equality and gender equity 
are used frequently [37]. However, what are the differences between these 
concepts?  
“Gender equality means the absence of discrimination on the basis of 
a person’s sex, in opportunities, allocation of resources or benefits, 
and access to services. […] Gender Equity means fairness and justice 
in the distribution of benefits, power, resources and responsibilities 
between women and men. The concept recognises that women and 
men have different needs, power and access to resources, and that 
these differences should be identified and addressed in a manner that 
rectifies the imbalance between the sexes.” WHO 2002: 3 [87]  
The United Nations adopted gender equality as its preferred term since the fourth 
world conference on women in Beijing (1995) [37, 88] and the notion has since 
been adopted by the majority of organisations and institutions charged with 
reducing inequalities between women and men. The concept of gender equity was 
considered to potentially allow social and cultural differences between women and 
men to persist, and was therefore frequently rejected. 
The World Health Organisation and other international organisations that 
manage health issues continued to use both terms – gender equality and gender 
equity – since they considered the notion gender equality to be too narrow and 
not to consider differences concerning health conditions and health care needs, 
such as those originating from biological sex differences [37].  
When it comes to education and employment, Payne and Doyal (2012) 
emphasised, it is social obstacles alone that prevent gender equality in terms 
of outcomes. However, in the context of health and health care, they claim, 
equity should be a crucial concept alongside equality since the biological sex 
differences between women and men prevail and are major determinants of 
health and health care needs. Failure to recognise this can create further 
inequalities between women and men [37].  
The Swedish context 
The gender equality policy in Sweden states that women and men are to have 
the same power to shape society and their own lives. From this key objective, 
the Government is working towards six sub-targets: power and influence, 
economic independence, unpaid housework and care, and men’s violence 
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against women [89]. Since 2016, two additional sub-targets have been added 
to the previous four; gender equality in health and care and gender equality in 
education. The former is defined as:  
“Women and men, girls and boys must have the same conditions for 
a good health and be offered care on equal terms.” [89] 
 
In a recent Swedish thesis, Smirthwaite [67] stressed that there are many 
similarities between women and men, but also differences, which the health care 
providers must consider in the provision of health care. If women are treated on 
the basis of knowledge and practices based on men (on a male norm), it may lead 
to inequalities, even if the treatment is the same. The same occurs if men are treated 
on the basis of knowledge that was mainly based on research on women. To 
achieve gender equality/equity  in the health care sector (Swedish; jämställd vård), 
Smirthwite stated, a prerequisite is that both health care services and medical 
research acknowledge that women and men are partly different and partly similar 
[67]. Smirthwaite states that Sweden has no established definition of gender 
equality/equity in health care (Swedish; jämställd vård) that all stakeholders 
accountable for health and health care services have agreed upon [67].  
 
Economic theory  
Scarcity, choices and opportunity costs 
Economics is the science of how choices are made in the context of scarcity. 
Because resources are essentially limited, choices have to be made. When a 
choice is made, recourses are forgone and cannot be used for something else. 
Choosing to spend resources in one way implies an opportunity cost; that is, 
the value of the best alternative to what was chosen [90]. 
Opportunity costs may involve resources measured in monetary terms (such as 
prices for goods and services) or/and as time spent, such as a forgone day of 
work or leisure time [32].  
Time spent on informal care can be valued as a production shortfall; that is, as 
a wage cost. An alternative valuation method is the replacement approach, 
valuing informal care in terms of what it would cost to have a professional 
health care personnel providing the care [90]. 
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Since it is not possible to meet all needs, demands and wishes with the resources 
available, choices have to be made about how to use them in the “best” way. “Best” 
refers to a choice that will give individuals the most satisfaction or utility or 
maximise population welfare; that is, the aggregate utility of a population.  
Efficiency in health and health care 
In a health care context, the objective is to pursue both efficiency and equity. 
Efficiency refers to maximising benefits – that is, utility in terms of health gains – 
with the resources available (or minimising costs for a given level of benefit). A 
commonly used efficiency definition is Pareto efficiency [90], a state where the 
resource allocation corresponds to a maximisation of benefits and where no one 
can gain without someone else being made worse off. A more versatile definition 
is the potential Pareto efficiency (or the Kaldor-Hicks criterion) [91, 92], which 
states that welfare improvements can be made as far as those that are made better 
off can “hypothetically” compensate those who are made worse off.  
Economic evaluation 
Economic evaluation is an approach that can assist when judgments have to be 
made that concern efficiency in resource allocation. According to Drummond et 
al. (2005) [90], two features characterise economic evaluation: it is a comparative 
analysis (that is, it compares two or more different options) and it compares these 
options in terms of their costs and consequences. 
There are several different categories of health economic evaluations available, 
where the main distinction refers to the consequences being measured, usually 
implying some kind of health unit or health benefit. Furthermore, a health economic 
evaluation requires a cost analysis in which costs for two or more different treatment 
alternatives are identified, quantified and valued in monetary terms. The costs to be 
considered depend upon the perspective. A societal perspective includes all costs 
within the society as a whole, such as consumption of health care resources, out-of-
pocket expenditure for the patient and their family, productivity losses and costs of 
informal care. Another, more limited perspective is that of the health care system, 
which only includes costs borne by the health care sector.      
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Overview of studied disease areas studied in  
studies II, III and IV 
Chronic kidney 
disease  
In patients with chronic kidney disease, the functioning of the 
kidneys gradually decreases over a period of time (a decreasing 
glomerular filtration rate) [93, 94]. Initial treatments are 
pharmaceuticals, remaining active, and dietary changes [95]. When 
renal function has deteriorated to 10 per cent of the kidneys’ normal 
ability, an end-stage renal disease (ESRD) is at hand. The number 
of patients with chronic kidney disease including ESRD is growing 
worldwide [96]. The increase of ESRD is mainly driven by 
population ageing, increased prevalence of type 2 diabetes mellitus 
and hypertension [96, 97]. 
End-stage renal disease ultimately leads to the need for renal 
replacement therapy, including kidney transplantation and dialysis. 
Most patients on dialysis use in-centre haemodialysis. Other 
available options include the home-based alternatives of peritoneal 
dialysis and home haemodialysis.  
The choice of 
dialysis treatment 
In several countries, including Sweden, patients with threatening 
ESRD are informed about different dialysis treatment methods, 
unless transplant is an available opportunity. In consultation with 
their physician and dialysis specialist nurse, patients should then  
be given the opportunity to choose the dialysis method that is most 
suitable for the individual patient. Consideration can, for instance, 
be that elderly and severely ill patients may have difficulties in 
managing home-based dialysis, which would require home health 
care services. 
In-centre 
haemodialysis  
(In-centre HD) 
In-centre HD is carried out in a hospital or dialysis centre and 
implies regular visits, usually three times a week for approximately 
four hours’ treatment each time. The patient is then connected to  
a dialysis machine through tubing, attached to a fistula or a graft 
inserted in the patient’s arm, for example. The blood is then filtered 
through the machine and waste products and fluids are removed 
from the blood. In some clinics, patients can be trained to manage 
some or all of the dialysis procedure by themselves. 
Home HD (HHD) Home HD means that the patient is managing the haemodialysis  
by him/herself at home. This requires training as well as some 
reconstruction in the home and space for a dialysis machine and 
storage of dialysis-related consumables and materials.  
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Peritoneal dialysis 
(PD) 
PD is also managed in the home by the patient, after a period of 
training. This method requires a catheter implant in the patient’s 
abdominal cavity. Dialysis fluid is then transferred into the 
abdomen through the catheter and remains there for several hours 
while waste products are removed. The dialysis fluid is 
subsequently tapped out and new fluid is filed in. This method also 
requires space in the home for storing of fluids and materials. There 
are three different versions of PD: (i) continuous ambulatory 
peritoneal dialysis (CAPD), meaning manual fluid changes are done 
approximately four times a day; (ii) automated PD (APD), which is 
a machine operating the exchange of fluids during the night; and 
(iii) assisted CAPD or APD, meaning the patient receives assistance 
from a home health care service in managing the dialysis process.   
Psoriasis Psoriasis is a common chronic skin disease affecting between 2–3 
per cent of the world’s population, including approximately 250,000 
to 300,000 people in Sweden [98]. Psoriasis often flares up 
periodically and, in its most common form, is characterised by  
well-defined red plaques on the skin. The plaques are building up  
a severe amount of new skin cells. Skin symptoms include pain, 
itching and cracking. 
Eczema Atopic eczema is a chronic inflammatory itching skin disease. The 
disease is increasing in countries with good hygiene and good living 
standards, such as in Sweden. About 20 per cent of preschool 
children suffer from atopic eczema, as well as 8 per cent of other 
children and 8–10 per cent of the adult population [99]. 
Treatment for 
psoriasis and 
eczema 
 
Most patients with moderate-to-severe psoriasis and eczema will  
be referred to a specialist in dermatology in an urban area. The 
alternative treatments offered in 2003 for these conditions were: 
bathing and ultra-violet radiation (UV treatment) at a hospital or 
self-treatment at home. Patients are always prescribed topical 
treatment and emollients, either to supplement hospital treatment  
or as a stand-alone treatment.  
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Aim and research questions 
 
The overall aim of this thesis is to explore, from a cost perspective, patterns in 
women’s and men’s healthcare utilisation. The specific questions are: 
§ What are the differences between women’s and men’s total number 
of contacts and health care costs in different age groups and levels of 
care?  Which differences can be explained by reproductive and sex-
specific health care? What are the differences between women’s and 
men’s health care costs within the four most expensive disease areas 
– cancer, cardiovascular disease, diseases of the muscles and joints 
and mental health problems? 
 
§ Are medical factors, patient characteristics, scope and quality of 
received dialysis information, attitudes and perceptions towards 
home-based and in-centre dialysis associated with gender and current 
dialysis methods? 
 
§ What are the differences in public health-care-related expenses and 
health-related quality of life between women and men using different 
dialysis treatments and between patients with home-based and  
in-centre dialysis? 
 
§ Are there differences between women and men diagnosed with 
eczema and psoriasis, in terms of subsequent treatment and treatment 
costs?  
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Thesis overview and methods 
 
This thesis comprises the examination of sex differences in health care 
utilisation and related costs as presented in Table 1.  
Table 1. Overview of the four studies in the thesis 
Study Aim 
Participants Data analysis/statistics 
Data collection Gender/sex 
Study I:           
Sex differences 
in health care 
consumption in 
Sweden: A 
register-based 
cross-sectional 
study 
To examine (1) total number of 
care contacts and costs for 
women and men and (2) to 
determine the impact of care 
due to reproduction and sex-
specific morbidity. (3) To 
examine sex differences by age 
group and level of care. (4) To 
analyse sex differences in the 
distribution of costs in the four 
most expensive disease areas. 
Approximately 
1.2 million 
consumers of 
publicly financed 
health care 
services during a 
year in VGR 
Quantitative:  
Comparisons of 
costs and contacts 
 
Register data and 
health care costs 
Impact of sex on 
health care 
consumption 
Study II:  
Patients’ 
perceptions and 
factors 
affecting 
dialysis 
modality 
decisions 
 
To examine factors affecting 
women’s and men’s choice of 
dialysis method; medical 
factors, socio-demographics, 
distance to dialysis centre, 
scope and quality of dialysis 
information, perceptions 
towards different dialysis 
methods. 
 N=434 Quantitative: 
Logistic 
regression 
Questionnaire 
comprising a 
health literacy 
approach 
Impact of gender 
on modality 
distribution   
Study III:    
Health 
economic 
comparison 
between home-
based and in-
centre dialysis  
To examine differences in 
public health care-related 
expenses and health-related 
quality of life (HRQoL) in 
women and men undergoing 
different dialysis treatments and 
between patients on home-
based and in-centre dialysis. 
 N=422 Quantitative: 
Cost and utility 
analysis  
Questionnaire and 
register data on 
health care related 
costs 
Impact of sex on 
health care related 
costs and HRQoL 
Study IV       
“The Laundry 
Bag Project” – 
unequal  
distribution of  
dermatological 
healthcare 
resources 
between 
women and 
men  
To examine differences in 
treatments and treatment costs 
in women and men diagnosed 
with eczema and psoriasis. 
  
N=586 
N=646 
Quantitative: 
Comparisons of 
treatments and 
costs 
Records, registers 
and treatment 
costs 
Impact of gender 
on treatment 
distribution and 
costs 
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Study design  
All four studies in the thesis had a cross-sectional design, and three of them 
comprised health care utilisation and treatments costs during one year. Study 
IV included a follow-up. Study I investigated total publicly funded health care 
consumption for the 1.6 million inhabitants in western Sweden (Region Västra 
Götaland (VGR)). Studies II and III investigated all adults (>18 years) 
undergoing dialysis treatment in the VGR and holding a social security number 
and a home address in Sweden, and who responded to a survey (n=434). Study 
IV investigated all patients referred to the dermatological outpatient 
department at Danderyd Hospital (DH-Derm) diagnosed with eczema and 
psoriasis (n=586). For comparison, all patients at another treatment unit 
(Swedish Psoriasis Association centre, SPA, n=646) were investigated.  
 
Data collection and management 
In Study I, data were retrieved from the regional health care database (VEGA) 
on total publicly funded somatic and psychiatric health care consumption by 
VGR inhabitants. Data coverage included all care contacts provided by public 
and private providers within or outside the region. Care contacts were defined 
as patient visits to primary care, to specialist outpatient care, and care episodes 
and bed days in inpatient care. Costs for specialist outpatient and inpatient care 
within the region were assessed using standardised prices in accordance with 
the region’s compensation model. Publicly funded private care and care 
outside the region were assessed using the actual compensation paid to those 
providers. Costs for primary care visits were based on the region’s average cost 
for a visit to a medical doctor and the average cost for a visit to other health 
care personnel.  
From the total number of health care contacts, contacts due to reproduction 
were removed by excluding all visits to maternity and youth clinics and care 
contacts that had a main diagnosis due to reproduction, according to the 
International Classification of Diseases, 10th Revision [100]. In the next step, 
health care received for sex-specific morbidity was excluded. The selected 
diagnoses represent conditions that are directly associated with sex-specific 
organs or the reproductive system (for example, breast, cervical and prostate 
cancer) but do not include conditions that are more common in either sex. 
Furthermore, all disease areas in the International Classification of Diseases 
were assessed based on a cost perspective and the four most expensive areas 
were selected for analysis.  
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In Studies II and III, data on social security number, age, sex, and current 
dialysis modality were collected from the nine hospitals and centres 
performing dialysis and managing home-based dialysis in the region. The 
subject’s social security number was used to obtain full names and home 
addresses of the patients from The Government’s Person and Address Records 
(Statens Person och Adress Register, SPAR). A questionnaire was sent out to 
the study population, to which 434 patients responded, yielding a response rate 
of 70 per cent.		
The questionnaire was developed with the main purpose of investigating 
factors influencing the choice of dialysis modality and was based on 
discussions with nephrology and dialysis specialists at the Sahlgrenska 
University Hospital, a representative for the Swedish Kidney Association, 
researchers in health literacy, and existing knowledge about barriers and 
facilitators to home-based dialysis [101, 102] and health literacy [103-106]. To 
measure health-related quality of life (HRQoL), the RAND-36 [107] 
instrument was included together with common background questions. The 
final questionnaire comprised 41 questions including 31 sub-items and the 36 
questions in the RAND-36 instrument (totalling 107 items). (See the Appendix 
for all questions included in the survey, their source and how the questionnaire 
was assessed and tested.) 
In order to collect health care-related costs, each patient’s social security 
number was used to retrieve individually generated health care cost data from 
the regional health care database (VEGA) and for pharmaceuticals, from the 
regional pharmaceutical database (Digitalis). These databases capture 
information on all publicly funded health care and pharmaceuticals, utilised 
and dispensed by the residents in the region. A more detailed description of 
how the health-care related cost were generated, including travelling and 
transportation costs, is presented in the Materials and Methods section in Study 
III. 
In Study II, data from the dialysis centres on age, sex, and current dialysis 
modality, as well as responses to the questionnaires, were entered into SPSS 
(version X6.0.2). In	Study	III, data from Study II were moved to the software 
program SAS 9.4 and 13 variables on health care service utilisation measured 
as costs were added. The SF-6D algorithm was used on RAND-36 responses 
to obtain a rating on the six health state domains and the preference-based 
summary health state index.  
In Study IV, the computerised medical records system used at DH-Derm was 
searched in order to determine the number of men and women who had sought 
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treatment for eczema or psoriasis. The records were searched using the search 
terms “diagnosis,” “prescription,” “UV treatment” (including different types 
of UV light), and “bathing”. In the next step, treatment costs were obtained by 
using codes based on standard calculations of the costs for various treatments, 
used by the hospital-based dermatology clinics throughout the Stockholm 
County Council. 
In order to make data more compatible to the second treatment unit (SPA), the 
records search was narrowed to the most homogenous and common diagnosis 
group within psoriasis, psoriasis vulgaris (plaque psoriasis, ICD code L400). 
Sex-disaggregated data on the number of patients and UV-treatments were 
then collected from the second treatment unit (SPA). Lastly, data from the 
pharmacy were collected concerning medications dispensed for topical skin 
treatment to patients at DH-Derm and to patients in the entire Stockholm 
County Council area. Data on patients and treatments were entered into the 
software program STATISTICA v. 7.0. 
 
Data analysis and statistics  
In Study I, the total number of health care contacts and related costs, before 
and after the exclusion of health care contacts due to reproduction and sex-
specific morbidity, were analysed on the basis of average distribution per 
capita for women and men by age group and level of care. Additionally, the 
four most expensive disease areas – cancer, cardiovascular disease, diseases of 
the muscles and joints, and mental health problems – were, after adjustment 
for sex-specific conditions, analysed on the basis of average cost distribution 
per capita and level of care for women and men. The chi-square test was used 
to test for statistically significant differences between women and men.  
In Study II, as a first step, bi-variable logistic regression analyses were carried 
out with the dependent variable being the current dialysis modality, 
dichotomised into in-centre HD and home-based dialysis (the latter including 
PD and HHD), and independent variables. The independent variables 
described patient characteristics, medical factors, and information received 
before dialysis onset.  
Information received was described by two variables. The first variable 
included the number of sources of information on dialysis that the respondent 
had acquired or received before dialysis onset, and the second variable 
measured the range and quality of the information and was expressed as an 
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index. The index included nine items and had a Cronbach’s alpha of 0.81 
(range 0–1), suggesting satisfactory internal reliability. For a further 
description of the independent variables, see the Materials and Methods section 
in study II. P values and odds ratios (ORs) with 95 per cent confidence intervals 
(CIs) were calculated and presented. 
In the next step, a logistic regression analysis was carried out with the selected 
statistically significant variables from the bi-variable analysis as explanatory 
variables for home dialysis. This analysis was performed on the total dataset 
and stratified by sex. To further deepen our understanding of how the received 
information was associated with current dialysis modality, 12 questions 
regarding information were analysed separately. The Fisher’s exact test (two-
sided) was carried out to test for statistically significant differences in answers 
between patients with home dialysis and patients with in-centre HD treatment, 
as well as differences between women and men. In order to understand which 
attitudes and perceptions toward home-based dialysis and in-centre HD affect 
the choice of dialysis method, responses to 19 statements on various aspects of 
different dialysis modalities were analysed. Again, Fisher’s exact test (two-
sided) was performed to test for statistically significant differences in answers 
between patients with home dialysis and patients with in-centre HD treatment, 
as well as differences between women and men.  
In Study III, the Fisher’s Exact Test and the Mantel-Haenszel Chi Square was 
used to investigate any differences in dialysis method distribution by gender. 
To test for statistically significant differences in patient characteristics between 
patients with different dialysis methods, as well as differences between women 
and men, the Fisher’s Exact Test and the Mantel-Haenszel Chi Square Test 
were performed. This testing was followed by tests between the same patient 
groups as in the previous test, regarding the six dimensions of HRQoL and the 
summary index of SF-6D, using the Mann-Whitney U-Test. In the next step, 
differences in terms of health care–related costs between the same patient 
groups were analysed, again using the Mann-Whitney U-Test. Finally, 
analyses of covariance (ANCOVA) were conducted to identify whether 
patients’ characteristics had a statistically significant impact on the health-
care-related costs or on the SF-6D summary index for patients with in-centre 
HD treatment and patients with home-based dialysis.  
In Study IV, t-test was used to identify differences regarding the ratio of women 
and men receiving treatment.  
In Studies I–IV, all hypothesis testing was evaluated using the 5 per cent 
statistical significance level. 
Women’s and men’s health care utilisation from a cost perspective 
 
20 
 
Ethics  
Studies II and III received ethical approval from the Regional Ethics 
Committee in Gothenburg (Dnr: 386–15). Before inviting the dialysis patients 
to the study, participation was confirmed by the nine dialysis centres in the 
region, to avoid sending questionnaires to deceased individuals or to patients 
who were no longer on dialysis treatment. An information letter was then sent 
out to each patient with a description of the study, stating that the patient would 
within two weeks receive a questionnaire and an invitation to contact the 
responsible researchers if they had any questions or wished to decline 
participation. A further information letter was sent out to the participating 
patients, together with the questionnaire, describing the handling of collected 
data and stating that their participation was voluntary and could be withdrawn 
at any time. Moreover, by filling out the questionnaire and sending it back in 
the enclosed envelope, they were, as stated in the letter, considered to have 
agreed to participate in the study.  
Regarding Study I, ethical approval was not required due to the Regional Ethics 
Committee in Gothenburg since data in the study were aggregated and 
impossible to link to specific individuals. Study IV was carried out as part of a 
quality assessment in the health care system provided by Stockholm County 
Council. Owing to the nature of the investigation, ethical approval was not 
required as communicated by the Regional Ethics Committee at Karolinska 
Institutet (see 2006/1387-31).  
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Results 
 
Study I 
The results of Study I showed that total per capita cost for health care was 20 
per cent higher for women than for men and that the difference was largest for 
primary care and smallest for inpatient care. When health care consumption 
was adjusted for reproduction, the cost-difference declined to 10 per cent. After 
further adjustment for costs associated with sex-specific morbidity, the 
difference decreased even further, to 8 per cent. 
 
 
 
 
Figure 2. Cost ratio, female/male, before and after adjustment for 
reproduction and sex-specific morbidity, by age group   
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The total reduction was greatest for women of reproductive age (see Figure 2) 
and was reflected in all levels of care. The remaining cost difference could be 
explained by women’s substantially higher costs for mental health problems 
and diseases of the muscles and joints. Women were more likely to receive 
more accessible and less expensive primary care, while men were more likely 
to receive specialist inpatient care; the latter was particularly evident in age 
groups 45 years and older (see Figure 3).  
 
 
 
 
 
Figure 3. Health care costs (€) after adjustment for reproduction and  
sex-specific morbidity 
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The finding that women and men receive care at different care levels was also 
evident in the four most expensive disease areas: cancer, cardiovascular 
disease, diseases of the muscles and joints, and mental health problems (see 
Figure 4). Even in cases when total healthcare costs were higher for men 
(cardiovascular disease and cancer), primary care costs were higher for 
women. 
 
Figure 4. Female-to-male ratio for per capita health care cost by level of care 
for the most expensive diagnostic areas, after adjustment for sex-specific 
conditions 
 
 
Study II  
The results of Study II showed that men were more than three times more likely 
to receive home dialysis if they lived with a spouse compared to if they lived 
alone – an association that was not observed for women (Table 2). Patients 
were more likely to have home dialysis if they received pre-dialysis 
information from three or more sources and, to a greater extent, perceived the 
information as comprehensive and of high quality. In addition, patients had a 
greater likelihood of receiving home dialysis if they lived further away from a 
dialysis centre, and if they were younger.  
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Table 2. Associations between dialysis modality and selected variables 
 Women, n=132 
Home dialysis,  
n=43 
Men, n=278 
Home dialysis,  
n=84 
All, n=410 
Home dialysis, n=127 
 OR 95% CI OR 95% CI OR 95% CI 
Age (years) 0.97* 0.94–0.99 0.99 0.97–1.01 0.98* 0.96–0.99 
Living situation       
Living alone (ref) 1  1  1  
Living with spouse 1.46 0.62–3.44 3.08*** 1.54–6.14 2.40*** 1.43–4.02 
Distance to 
centre/hospital 
(per 10 km) 
 
 
1.31** 
 
 
1.08–1.60 
 
 
1.21*** 
 
 
1.08–1.35 
 
 
1.23*** 
 
 
1.12–1.35 
Sources of information       
0–2 sources (ref) 1  1  1  
3 or more sources 2.60* 1.10–6.16 1.69 0.96–2.97 1.88** 1.18–3.00 
Index of scope and 
quality of information,   
Range 18      
 
 
1.05 
 
 
0.96–1.15 
 
 
1.07* 
 
 
1.01–1.14 
 
 
1.06* 
 
 
1.01–1.12 
The analyses are based on multiple logistic regression with the dependent variable dichotomised 
into home dialysis and in-centre HD (the latter is the reference category). 
*** P<0.001, ** P<0.01, * P<0.05 
In the in-depth analysis of associations between received information and 
current dialysis method, it became evident that in-centre dialysis patients more 
often reported a need for more frequent and thorough information on dialysis 
in general (p<0.05) and more information on PD in particular (p<0.001); they 
would also appreciate receiving information electronically (for example, by 
computer, app, or DVD) or as a brochure (p<0.05). Women reported to a lesser 
extent than men that they had received information about different dialysis 
modalities and that sufficient information about home HD was given (p<0.05).  
Regarding the analysis of which perceptions and attitudes are affecting the 
choice of dialysis method, the results showed no significant difference between 
women and men. However, patients on in-centre HD believed to a greater 
extent than those on home dialysis that the social interaction with staff and 
fellow patients, together with support and help induced by having in-centre HD 
and the total freedom from dialysis some days a week, influences modality 
choice. On the other hand, home dialysis patients believed that the choice is 
affected by home dialysis as a treatment requiring (i) a lot of space in the home, 
(i) more personal responsibility, and (iii) implying that the patient is feeling 
better. Home dialysis patients also perceived home dialysis, to a greater extent, 
as a burden on family and relatives and as imposing increasing out-of-pocket 
expenditures.			
Ingrid Osika Friberg 
25 
 
Study III  
Results regarding health-related quality of life (HRQoL) in Study III showed 
that in-centre HD patients reported more pain and a lower social functioning 
compared to patients receiving home dialysis. Women on in-centre HD 
treatment reported poorer mental health and lower vitality than corresponding 
men. Nevertheless, no significant differences in the summary index of health-
related quality of life were observed between women and men or between 
patients on in-centre HD and on home dialysis.  
When analysing HRQoL for patients on PD and HHD separately, patients on 
HHD had a better physical function and a higher summary index of HRQoL 
compared to patients on PD. Women on HHD had worse social functioning 
and worse mental health state than corresponding men. However, it should be 
noted that there were few patients with HHD treatment and they were, on 
average, 12 years younger and had a higher educational level and a lower mean 
of co-morbidities than patients on PD.  
The total annual dialysis-related health care cost was 2.5 times higher for 
patients on in-centre HD than for patients on home dialysis (Figure 5). The 
corresponding number for dialysis- and renal-related health care cost was 2.2.  
No significant differences were found between women and men, or between 
patients receiving PD and HHD regarding total dialysis-related health care 
costs, total dialysis- and renal-related health care costs, or overall health care 
costs. The only cost items that demonstrated significant differences were 
attributed to pharmaceuticals within home dialysis. Patients on HHD revealed 
higher costs for dialysis-related pharmaceuticals than patients on PD, and men 
on home dialysis exhibited higher costs for other renal-related pharmaceuticals 
than women. 
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Figure 5. Annual average health care related costs, in in-centre and home dialysis 
patients, 2015 
The analyses of covariance (ANCOVA) showed no influence of mean age, sex, 
educational level, native language, living situation (living alone or together) or 
mean number of co-morbidities on the dialysis-related health care costs or the 
dialysis- and renal-related health care costs. Nevertheless, the mean number of 
co-morbidities had a statistically significant impact on the SF-6D summary 
index, but differences between in-centre and home dialysis remained 
insignificant.  
The public health care provider can expect an annual gross cost saving of 
€48,700 for every patient who chooses a home-based dialysis treatment over 
in-centre dialysis treatment. 
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Study IV  
The result of Study IV showed that as many women as men with a diagnosis of 
eczema or psoriasis sought treatment at DH-Derm (Table 3). Bathing treatment 
was administered 456 times to these patients and whole-body ultraviolet 
radiation (UV treatment) was administered on 2,140 occasions. A substantially 
larger group of men (63 per cent) than women (37 per cent) received whole-
body UV treatment for psoriasis or eczema (P < 0.0001). No apparent gender 
differences regarding the severity of symptoms could be identified from the 
patient records for these diagnoses.  
Table 3. Treatment of women and men with eczema and psoriasis, DH-Derm, 2003 
 
 Patients 
diagnosed 
with 
eczema,  
n (%) 
Patients 
diagnosed 
with 
psoriasis,  
n (%) 
Patients 
diagnosed 
with eczema 
or psoriasis, 
n (%) 
Patients with 
bathing 
treatment,  
n (%) 
Patients with 
UV-
treatment,  
n (%) 
Women 134 (52) 157 (48) 291 (50) 46 (52) 47 (37)*** 
Men 126 (48) 169 (52) 295 (50) 42 (48) 79 (63) 
Total 260 (100) 326 (100) 586 (100) 88 (100) 126 (100) 
*** =p < 0.0001 regarding treatment differences between women and men. 
When the treatments for men and women with eczema and psoriasis were 
priced, it was found that women’s treatment costs were US$ 31,750 less than 
men’s treatment costs, equivalent to 22 per cent of the treatment budget. 
In order to make the treatment figures comparable with other clinics 
performing UV treatment for psoriasis, analyses were conducted on the 
number of treatments per individual diagnosed with psoriasis vulgaris, the 
numerically largest diagnosis group. Corresponding data were collected from 
a second psoriasis treatment unit, SPA (Table 4).  
 
Table 4. Ultra-violet radiation (UV) treatment of women and men with psoriasis, DH-
Derm and SPA, 2003  
 
  Number of 
individuals 
%  Number of 
treatments  
Number of 
treatments/patient 
(mean value)  
% 
DH-Derm Women 38 44 768 22.2 38* 
 Men 48 56 1244 25.9 62 
SPA Women 273 42 5369 19.6 36*** 
 Men 373 58 9712 26.0 64 
*= p < 0.05, *** =p < 0.00001 regarding treatment differences between women and men. 
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Data from DH-Derm and SPA showed that men received significantly more 
UV treatment for common psoriasis than women.  
Prescriptions for self-care topical treatment were issued to all patients 
diagnosed with psoriasis or eczema. A straightforward assumption was that 
patients who did receive self-care as a stand-alone treatment performed more 
self-care with topical skin medications than those who received treatment in 
the clinic. Data from Apoteket were analysed concerning medications 
dispensed for topical skin treatment for patients at DH-Derm and for the 
Stockholm County Council as a whole (Figure 6), with similar results.  
 
D05X is a topical treatment for psoriasis. Oxoralen are tablets taken in connection with a 
particular UV-treatment (PUVA). ***= p < 0.001 
Figure 6. Dispensed prescriptions in Stockholm County Council in $US, 2003 
The total value of medication dispensed to women was greater than the total 
value of medication dispensed to men (P<0.001), and the largest sex difference 
was present in emollients.  
The results of this investigation were discussed with the staff at DH-Derm 
and a follow-up regarding UV treatments for psoriasis patients was carried 
out one year later. The result from the follow-up did not show statistically 
significant treatment differences between women and men, which is at odds 
to the previous year.  
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Discussion 
 
Defining gender equality and equity in the context of health care 
The opening paragraph in the Swedish health and medical services Act (Law 
1997:142), together with the ethical platform for health care priority-setting, 
constitute the fundamental ethical principles on which the Swedish health care 
system is based. The first ethical principle refers to non-discrimination in the 
health care sector; that is, an equality principle. The second refers to need and 
solidarity; that is, an equity principle. The third (not included in the 
formulation of the Law 1997:142) stresses that cost-effectiveness should be 
considered. 
As the present thesis explores women’s and men’s health care utilisation from 
a cost perspective, it is important to clarify what these principles mean from a 
sex/gender perspective in a Swedish health care context. 
When considering both international and Swedish standpoints regarding the 
concepts of gender equality and gender equity in health and health care, it 
becomes clear that the content of both concepts is essential. When it comes to 
justice and fairness between women and men receiving health care, the 
concepts and definitions need to be comprehensive and have the ability to 
cover the complexity of the issue. Based on the established concepts of equality 
and equity, and with the presented standpoints, I recommend the content of 
both concepts, as suggested in boxes C and D in Table 5.  
Table 5. Gender equality and equity in the context of health care provision in Sweden 
A Equality  
Ensure that people in equivalent 
circumstances are treated the same 
(e.g., in relation to geographical 
location or suffering from the same 
condition). 
 
Gender equality is included in 
Equality.  
B Equity 
Ensure that people (or communities) who are in 
unequal positions/circumstances are treated 
differently, in a way that is commensurate with 
their relative disadvantage (e.g., in relation to 
disabilities or a worse health due to 
socioeconomic position).   
Gender equity is included in equity but represents 
a distinct position. 
C Gender equality 
Ensure that women and men and 
other sexualities in equivalent 
circumstances (i.e., when they have 
D Gender equity 
Ensure the provision of different treatment in 
accordance with biological sex-differences (e.g., 
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equivalent needs and the biological 
sex differences are irrelevant) are 
treated the same. 
  
in relation to reproduction and sex-specific 
diseases), 
- and sex-adjusted treatment (e.g., in relation to 
areas were knowledge about both (all) sexes are 
essential for a successful outcome  
- Gender equity also implies that medical research 
and the health care sector prioritises health 
problems and diseases that occur, or mainly occur 
in one of the sexes, to the same extent as other 
medical problems.  
 
Cost differences in health care utilisation between women and men 
There are similarities and differences between women’s and men’s health care 
utilisation. Study I revealed that, at an overarching regional level, women 
annually consume 20 per cent more health care resources than men. However, 
much of these additional costs relate to women’s health care associated with 
reproduction. Hence, they should conceptually be seen as a sex specific need 
referring to the gender equity concept. From an economic perspective, this 
consumption is a matter of investing in new society members, as opposed to a 
cost that emanates from treatment of disease; that is, a distinct case of human 
capital investments. A further share of women’s additional costs was related to 
their greater health care utilisation due to other sex-specific conditions than 
reproduction, consequently also referring to the gender equity concept (I). The 
remaining share could be explained by women’s substantially larger costs for 
mental health problems and diseases of the muscles and joints (I). On the other 
hand, men exhibit higher health care costs for cancer and cardiovascular 
disease in relation to women (I). It should also be noted that chronic kidney 
disease, which is the main reason why renal replacement therapy is needed, is 
clearly linked to cardiovascular disease [97]. Studies II and III revealed that 
two-thirds of patients receiving dialysis treatment were men, which implies 
higher total health care-related cost for dialysing men. In contrast, when the 
average annual health-care-related costs for dialysis treatment were analysed 
through stratifying by sex (III), no cost differences between women and men 
were observed. This result should conceptually be referred to as gender 
equality, as it demonstrated an almost gender equal distribution of publicly 
funded health care resources between women and men with the same treatment 
method.   
The treatment cost for eczema and psoriasis at the outpatient specialist clinic 
in Stockholm exhibited substantially greater cost for men than for women, with 
no apparent clinical difference in symptom severity between the sexes (IV). 
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Concurrently, higher costs for topical skin medications were noted for women 
than for men. Accordingly, these results demonstrate gender in-equality in the 
distribution of public health care resources. Interestingly, discussions about the 
disclosed findings among the clinical staff led to the differences disappearing 
at a follow-up one year later regarding-UV treatment in patients with common 
psoriasis (IV). This demonstrates the importance of knowledge and attention 
of staff regarding unequal treatment patterns, thus leading to rather rapid 
changes.  
Another important result refers to cost differences between women and men in 
terms of utilised level of care (I). Women are more likely to consume less 
expensive primary care, while men are more inclined to consume more 
expensive specialist care, particularly in older age groups. This pattern is also 
evident in the four most resource demanding diagnostic areas, where women 
had a higher share of primary health care costs in all four areas (cancer, 
cardiovascular disease, diseases of the muscles and joints, and mental health 
problems) in relation to their total costs for these diagnostic areas. Notably, 
this was even true regarding cardiovascular disease and cancer, where men 
exhibited higher total costs. Given the cost differences between women and 
men within the four most resource demanding diagnostic areas, and the utilised 
level of health care, more in-depth analyses are needed in order to assess the 
differences from a gender equality and equity perspective.  
Informal care 
The treatment differences for eczema and psoriasis (IV) implied that the 
outpatient specialist clinic funded treatments of men’s skin diseases to a greater 
extent than women’s, whilst women were more inclined to self-care in their 
home. Additionally, men who underwent dialysis treatment were three times 
more likely to receive home-based dialysis if they lived with a spouse 
compared to if they lived alone – an association that was not observed for 
women (II). Accordingly, results showed that home-based dialysis was 
substantially less costly than in-centre HD treatment (III). This suggests that 
women’s provision of support and informal care towards men on dialysis 
enable them to choose a dialysis treatment that saves a lot of publicly funded 
health care resources. These findings are consistent with traditional gender 
norms, implying that women in general provide more informal care and 
support to family members than men do [108, 109], and research findings 
indicating that men benefit more from informal care than women [110].  
Women’s contribution of informal care (in the present studies, self-care and 
partner care) are unrecognised and unaccounted for in the Swedish National 
Women’s and men’s health care utilisation from a cost perspective 
 
32 
Accounts and gross domestic product (GDP). As such, it can be considered as 
a hidden subsidy to the health care sector that should be recognised and valued 
[111]. A health economic evaluation from a societal perspective comprises 
both measurement and valuation of informal care. However, this does not 
imply that the measured value of informal care is included in the National 
Accounts and gross domestic product (GDP). 
Researchers have estimated the financial value of women’s contributions of 
unpaid health care work to 2.35 per cent of global gross domestic product 
(GDP) [111]. The estimation was based on data from 32 countries, accounting 
for 52 per cent of the world’s population in 2010. The total value of women’s 
unpaid care work is estimated to be considerably higher [111].  
The health care utilisation approach 
The health care service utilisation approach presented earlier in this thesis (see 
Figure 1; Liss 1990), provides a conceptual framework for analyses of the 
included studies (I – IV) and illustrates the dynamics behind health care 
utilisation [16]. The figure depicts how the three concepts of health care need, 
demand and supply overlap each other and shape the actual health care 
utilisation; that is, areas B and G (Figure 7). In situations when an individual’s 
demand for health care correspond to the health care provider’s 
recommendation of health care – that is, the supply – it leads to utilisation. It 
is difficult to estimate the size and proportions of the different areas in the 
figure except for the size of the actual health care utilisation (area B and G). 
The proportions of the remaining areas, especially those involving health care 
need, are mainly an empirical matter.  
The sex and gender aspects of the determinants of health are expected to affect 
the need for health care; that is, the size of women and men’s area 1 (Figure 
7). Gender differences in need and barriers to seek health care are expected to 
affect the demand of health care; that is, women and men’s size of area 2. 
Further, differences in the health care provider’s recommendation – i.e. the 
structure of the supply side – are expected to affect the health care available 
and treatments provided to women and men, area 3.  
Study I comprises visits and costs occurring in the total area of B and G for the 
population in VGR. Based on the result in this study, all three areas in the 
model are larger for women than for men, mainly depending on health care 
needs in connection with reproduction and sex-specific morbidity, together 
with gender differences in the demand of health care for diseases of the 
muscles and joints and mental health problems. However, gender differences 
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in the supply side were also evident regarding the level of health care provided 
to women and men.  
Studies II, III and IV can mainly be seen as sub-parts of area B and G. In Study 
II the patient’s choice of dialysis method (that is, demand for treatment) was 
affected by various factors including gender relations; that is the informal care 
provided by spouses. The informal care could be referred to area E, where 
individual’s health care needs are present, however met by informal care in 
contrast to formal health care provision. The result in Study III exhibits no 
gender differences regarding treatments and treatment costs. Nevertheless, the 
proportion of in-centre dialysis treatments that could be replaced by home 
dialysis without social and medical impairments, could be referred to area B, 
an area described by Liss [16] as inefficient use of resources i.e. “no providers 
recommendation without available resources”.  
In Study IV the health care provider (i.e. the supply side) revealed a gender-
biased treatment distribution, which meant that men received more treatments 
for two common skin diseases, where no gender differences regarding the 
severity of the illnesses could be observed. Consequently, women 
compensated for this gender bias with informal self-care (once again referring 
to area E where health care needs are met by informal care, i.e. self-care).  
 
 
Figure 7. The health care service utilisation approach (Liss, 1990) [16] 
Area F refers to a situation where the individual has a need and demand for 
health care but there is no provider’s recommendation (i.e. no supply). In 
relation to sex and gender, one could speculate that such a situation may occur 
due to biases in the health care system and a skewed distribution of investing 
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in health research [8, 111]. Research indicates a slower recognition of health 
problems particularly affecting women, which will have consequences for the 
level of knowledge, priorities and implementation of treatments [8, 111-114]. 
In certain areas, this may also apply to health problems particularly affecting 
men, such as the research and ongoing discussion regarding prostate screening.  
Johnsson et al. suggest that parts of women’s actual higher health care 
utilisation rates might reflect frustration over inadequate treatment and 
ineffective care, for example regarding women who repeatedly seek treatment 
for chronic pain [14]. This phenomenon could probably, to some extent, be 
related to the finding in Study I, which showed that women had a substantially 
higher cost for diseases in muscles and joints, generally associated with pain 
[115].  
Area D refers to a situation where the individual’s need for health care is 
present and the health care providers recommend treatment, but the individuals 
are not demanding it. This situation can be understood as barriers to seeking 
health care. Men are considered to be more reluctant than women to seek health 
care, except in cases of acute illness [57, 61]. On the other hand, women’s 
substantially greater use of reproduction-associated care already at a young 
age, which largely occurs within primary care, as shown in study I, might make 
it easier for them to also seek health care for other reasons. Therefore, women 
can be considered to be socialised to seek health care to a greater extent than 
men. Efforts to eliminate barriers that prevent men from investing in their 
health and seeking primary care could reduce future morbidity and costs for 
specialist care.  
Collectively, on the basis of the included studies it is clear that the size of the 
areas and their overlapping (Figure 7) differ between women and men. In terms 
of the sex and gender determinants of health to health care utilisation, the sex-
disaggregated health care service utilisation approach can help determine 
where in the process differences between women and men occur.  
To achieve cost-savings in dialysis treatment 
The results of Study III show that cost savings could be realised if more dialysis 
patients and pre-dialysis patients suitable for home-based dialysis would be 
supported to choose these less resource-demanding dialysis methods. Hence, 
to realise a resource allocation where no one is made worse off – instead, 
someone else is gaining – by making resources available for other purposes. 
To reach this goal, the results in Studies II and III showed that conscientious 
measures on both a more overarching, as well as at a patient interaction level, 
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need to be taken into consideration to reduce barriers to home-based dialysis 
compared to in-centre HD. First, an evaluation and probably alteration of 
financial incentives and policies in order to promote home dialysis. Second, 
ensuring all patients and their relatives repeated, comprehensive, high-quality 
information, including considerations to use new ways to dispense 
information, such as electronically. It is also important that the information and 
support is adapted to the specific needs of different patients, patient groups and 
their relatives, taking gender into account. As the results in Study II indicated, 
women experienced to a lesser degree than men that they had received 
sufficient information about different dialysis methods, especially home HD. 
Further, as lonely living patients or relatives of pre-dialysis patients, men may 
require additional information and support in order to facilitate them or their 
spouse to choose a home-based dialysis method. A suggestion is to invest in a 
health-literate health care organisation [116, 117], characterised by the ability 
to meet the needs of populations with varying health literacy skills. (Health 
literacy is often defined as an individual’s ability to access, understand, 
appraise, and apply health-related information [118].) 
The results generally suggest the need for more support for home-dialysing 
patients and their relatives, including financial support to compensate for 
increased out-of-pocket expenditures associated with home dialysis, as well as 
increased social interaction, which according to patients on in-centre HD 
proved to be a core aspect in the choice of in-centre HD.  
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Conclusion 
 
This thesis establishes the following conclusions, from an overarching regional 
level to an individual patent level. 
 
Ø In Sweden, there are substantial differences between women’s and 
men’s health care consumption at an overall level, and within various 
disease areas and conditions, and in terms of utilised level of care. 
 
Ø Many of women’s additional costs are related to health care contacts 
associated with reproduction and should consequently be seen as a 
specific issue because they are primarily a question of investing in 
new society members and not costs related to disease treatment, 
which makes them a distinct form of human capital investment.   
 
Ø It is essential to take the gender distribution of informal care, 
including self-care and partner care, into account when analysing 
women’s and men’s health care utilisation, since informal care 
represent a hidden, potential gender biased, subsidy to the health care 
sector. 
 
Ø There are a number of factors associated with home-based dialysis, 
such as recurrence, scope and quality of pre-dialysis information and 
cohabitation (the latter only concerns men). Likewise, social 
interaction, support and out-of-pocket expenditures affect the choice 
of the dialysis method. 
 
Ø Total annual dialysis-related health care cost is more than twice as 
high for patients on in-centre HD than for patients on a home-based 
dialysis method in western Sweden (VGR). There are no cost 
differences between women and men or between the home-based 
methods, peritoneal dialysis and home haemodialysis.  
 
Ø To detect differences in health care utilisation for women and men, it 
is important to analyse data disaggregated by sex.  
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Future perspectives 
 
It is important to disaggregate and analyse public health care spending by 
gender, preferably together with other sociodemographic factors, in order to 
enable transparency and accountability of the health care sector. Likewise, the 
scope and gender distribution of unpaid care work must concurrently be 
analysed and addressed. Given the prevailing situation of limited health care 
budgets, such analyses are important to ensure that women and men receive 
gender equal and equitable health care services, adhering to the ethical 
principles on which the Swedish health care system is based, and to avoid (an 
increasing bulk of) gender biased informal care.   
Health care cost related to reproduction is a special form of health care that 
comprises a large share of women’s additional health care costs compared to 
men. Consideration should be made to set up a specific budget line, within the 
health care budgets, that covers health care costs for investments in new society 
members. This distinct form of human capital investment includes both public 
and parental expenses, as well as unpaid care work and physical hardship for 
mothers. Hence, the health-economic toolbox should be used to assess the total 
societal cost of investing in new society members.  
Moreover, women’s substantially greater use of reproduction-associated care 
at a young age, which largely occurs within primary care, can be viewed as a 
form of training in seeking health care. Apparently, this does not apply to men. 
Efforts to make it easier for men to invest in their health by seeking primary 
care, and preferably to do so earlier, could reduce future morbidity and costs 
for specialist care. To achieve this, consideration should be made to support 
schools and youth clinics to engage in boys’ and men’s health to a greater 
extent. Furthermore, more research is needed that compares women’s and 
men’s health-care-seeking behaviour for different health conditions. 
Another important issue is to determine why women are overrepresented 
regarding mental health problems and diseases of the muscles and joints, which 
often also occur as co-morbidities. Efforts and interventions are needed to 
decrease these distressing and costly conditions by providing good access to 
health care services with high-quality treatment. Additionally, the causes of 
these illnesses often seem to be related to living conditions, including work 
and family life, which also need to be addressed.  
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Regarding the importance of information and support to dialysis and pre-
dialysis patients and their relatives, it is evident that there is room for 
improvement in order to boost patient empowerment with increased use of 
home dialysis. The greater the number of patients that use home dialysis, the 
more savings of public resources will occur. The implementation of 
strengthened information and support strategies must also be evaluated 
capturing consequences for patients and their relatives. 
In the light of the recently adopted gender equality goal in Sweden; gender 
equality in health and care, it has become crucial to understand what this 
goal actually implies in the context of health care utilisation. Although the 
issue is complex, progress has been made regarding the clarification of the 
concepts of gender equality and equity in health care. This is important given 
that the ethical principles on which the Swedish health care system is based, 
rest on principles of equality and equity. There is unfinished work still to be 
done regarding, for example, sex and gender in relation to the priority 
dimension of the Medical Services Act and the ethical platform for health 
care priority-setting, demanding that different health care needs are to be 
assessed, analysed and ranked. 
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Appendix 
 
The questionnaire was discussed in two research groups at the Section for 
Epidemiology and Social Medicine at the Sahlgrenska academy and assessed 
by researchers in nephrology and health literacy. The questionnaire was then 
tested in a pilot study with 10 dialysis patients living outside the Region 
(VGR) recruited via an inquiry to the Swedish Kidney Association’s 
Facebook group and improvement was made in accordance with views 
expressed through written comments and telephone discussions with the 
patients. 
 
Alla frågor i enkäten 
Frågornas ursprung är angiven på höger sida eller i början av de olika 
enkätavsnitten. Svarsalternativen har utelämnats av utrymmesskäl. 
Bakgrund 
1. Vilket år är du född   (SCB, Frågebank över bakgrunds-  
2. Är du man eller kvinna  frågor, SCB 2004:2 m.fl.) 
3. Vilken typ av bostad bor du i    (SCB 2004 m.fl.) 
4. Med vem delar du bostad    (SCB 2004 m.fl  
5. Finns det barn i hushållet    (SCB 2004 m.fl.) 
6. Vilken är din högsta genomförda utbildning  (SCB 2004 m.fl.) 
7. Inom vilket yrkesområde har du huvudsakligen arbetat  
   (Arbetsförmedlingen, lista över yrkesområden,  
   se http://www.arbetsformedlingen.se/) 
8. Vilket är eller har varit ditt huvudsakliga yrke?  (SCB 2004 m.fl.) 
9. Har du genomgått dialysbehandling de senaste 7 dagarna 
10. Vilket modersmål har du (Client service receipt 
inventory (CSRI) se 
nedan.) 
11. Om du har annat modersmål än svenska: Ange med vilka kontakter eller i 
vilka sociala sammanhang du talar svenska.       (Hälsolitteracitet)        
12. Förvärvsarbetar du för närvarande  (Arbetsbelastning, Ulf Lundberg)  
13. Om du inte skulle behöva genomgå dialysbehandling skulle du då ägna 
mer tid till förvärvsarbete.  
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Sjukdom  
(Huvudsaklig källa är samtal med och återkoppling på utkast till enkätfrågor 
från en grupp av forskare och kliniker inom området njurmedicin och 
dialysbehandling.  
14. Vilken är din njursjukdom                     (ULF/SILC 2014 SCB) 
15. Vilket år blev du diagnostiserad med njursjukdom 
16. Har du någon annan långvarig eller allvarlig sjukdom förutom din 
njursjukdom  
17. Har du genomgått någon operation i magen/buken innan det blev aktuellt 
med dialys för dig  
Dialysbehandling  
(Huvudsaklig källa är samtal med och återkoppling på utkast till enkätfrågor 
från en grupp av forskare och kliniker inom området njurmedicin och 
dialysbehandling.) 
18. När började du med dialysbehandling 
19. När hade du senast en dialysrelaterad infektion eller annan komplikation  
20. Vilken dialysbehandling har du för närvarande 
21. Sedan när har du haft den dialysbehandling du har för närvarande 
22. Hur ofta dialyserar du en genomsnittlig vecka 
23. Hur lång tid tar i genomsnitt din dialysbehandling per gång 
24. Har du haft någon annan form av dialysbehandling än den du har för 
närvarande 
 
Hälso- och sjukvårdskontakter  
(Client Service Receipt Inventory, CSRI är ett standardformulär för att mäta 
resursanvändning (Beecham & Knapp, 1992 & 2001; Chisholm et al., 2000). 
Flera CSRI enkäter som använts i publicerade studier användes i 
utformningen av nedanstående frågor).  
25. Under de senaste 3 månaderna vilka personliga besök har du gjort på 
vårdcentralen på grund av din njursjukdom eller dialys eller med anledning 
av komplikationer av dessa 
26. Under de senaste 3 månaderna vilka personliga dagbesök har du gjort på 
specialistmottagning/sjukhus på grund av din njursjukdom eller dialys eller 
med anledning av komplikationer av dessa 
27 a. Har du under de senaste 3 månaderna varit inlagd på sjukhus på grund 
av din njursjukdom eller dialys eller med anledning av komplikationer av 
dessa 
27 b. Om ja, fyll i detaljerna för varje tillfälle 
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Ej receptbelagda läkemedel, naturläkemedel, vitaminer, kosttillskott etc.   
     (CSRI se ovan)  
28. Skriv ner de ej receptbelagda läkemedel, naturläkemedel, vitaminer och 
kosttillskott som du använder p.g.a. din njursjukdom och/eller dialys 
29. Har du haft några andra personliga utgifter med anledning av din 
njursjukdom eller dialys de senaste 3 månaderna, utöver patientavgifter i 
hälso- och sjukvården och läkemedel/kosttillskott? 
 
Transport      
(CSRI, se ovan) 
30. Hur transporterar du dig vanligen till njurmottagningen/ 
dialysmottagningen/PD-mottagningen  
31. Ungefär hur lång är resan enkel väg? 
 
Hjälp och stöd i hemmet    
(RIKS-STROK och CSRI, se ovan) 
32. Får du hjälp av hemtjänst, hemsjukvård eller annan hjälp med anledning av 
din njursjukdom      
Hjälp och stöd av närstående   
(RIKS-STROK och CSRI se ovan) 
33. Får du stöd eller hjälp av anhörig/närstående i din vardag med anledning 
av din njursjukdom/dialys  
34. Hur lång tid får du aktivt stöd av en anhörig/närstående en genomsnittlig 
vecka  
 
Information, erfarenheter och åsikter  
(Frågorna är framtagna i samarbete med forskare inom hälsolitteracitet och 
på basis av studier om hälsolitteracitet samt studier kring barriärer mot olika 
dialysmetoder; Griva et al., 2011 and McLaughlin et al., 2003 och genom 
samtal med och återkoppling på utkast till enkätfrågor från en grupp av 
forskare och kliniker inom området njurmedicin och dialysbehandling.) 
35. På vilket sätt fick du information om dialysbehandling innan du 
påbörjade din dialys 
36. Här kommer att antal påståenden om den information du fått som vi vill 
att du tar ställning till 
 1. Jag fick information om olika dialysmetoder 
 2. Det gavs tillräcklig information om HD på sjukhus/mottagning 
 3. Det gavs tillräcklig information om hem HD 
 4. Det gavs tillräcklig information om manuell PD 
 5. Det gavs tillräcklig information om automatisk PD (nattmaskin) 
 55 
 6. Det gavs tillräcklig information om assisterad PD 
 7. Jag hade behövt information om dialys vid fler tillfällen 
 8. Jag hade behövt mer grundlig information 
 9. Den information jag fick var lätt att förstå 
 10. Utifrån den information jag fick var jag redo att fatta beslut om 
 dialysmetod 
 11. Det är relevant att jag själv fattar beslut om dialysmetod 
12. Jag skulle uppskattat information på annat sätt än på det sätt jag 
fick, exempelvis via datorn, via app i telefonen, via DVD film eller 
broschyr 
37. Jag har den dialysform jag har idag för att: 
38. Vilka påståenden anser du påverkar valet av dialysmetod 
 1. Vid HD på mottagning får man hjälp och stöd av sjukvårdspersonal 
 flera gånger i veckan 
 2. HD behandling på mottagning är tidskrävande 
 3. Tätare dialyser vid hem HD och PD innebär att man mår bättre 
 4. Hem HD och PD innebär att det blir en sjukvårdsmiljö i hemmet 
 5. Vid PD är det besvärande med en kateter i magen 
 6. PD har medicinska fördelar jämfört med andra dialysalternativ 
 7. Hem HD och PD kräver större eget ansvar 
 8. Vid PD är det besvärande att ha dialysvätska i magen 
 9. Hem HD har medicinska fördelar jämfört med andra dialysalternativ  
 10. Hem HD och PD är krångligt och svårt att sköta 
 11. Manuell PD är besvärande i sociala sammanhang 
12. HD på mottagning har medicinska fördelar jämfört med andra 
dialysalternativ 
13. PD innebär att man behöver ägna mindre tid till dialys jämfört med 
andra dialysalternativ 
 14. PD hämmar/stör samlivet 
 15. Hem HD och PD belastar familj och närstående 
 16. Hem HD och PD kräver mycket utrymme i hemmet 
 17. Med HD på mottagning är man helt fri från behandling en del dagar 
 i veckan 
 18. Hem HD och PD innebär högre egna utgifter 
19. HD på mottagning innebär att man regelbundet träffar personal och 
andra patienter.  
39. Vilken dialysbehandling anser du ger patienten störst frihet 
40. Vilken dialysbehandling anser du ger patienten störst trygghet 
41. Finns det fler åsikter eller faktorer som kan påverka val av 
dialysbehandling: 
 
Women’s and men’s health care utilisation from a cost perspective 
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RAND-36 Hälsa och livskvalitet  
RAND-36 är ett generiskt instrument för att mäta hälsorelaterad livskvalitet 
och kan beställas av Register Centrum SydOst. Instrumentet innehåller 36 
frågor där samtliga frågor har flera svarsalternativ (från 2–6).  
 1. I allmänhet, skull du säga att din hälsa är 
 2. Jämfört med för ett år sedan, hur skulle du bedöma din hälsa nu 
      
Begränsar din nuvarande hälsa dig i dessa aktiviteter: 
 3. Fysiskt ansträngande aktiviteter 
 4. Måttligt ansträngande aktiviteter 
 5. Lyfta eller bära matkassar 
 6. Gå upp för flera trappor 
 7. Gå upp för en trappa 
 8. Böja dig eller gå ner på knä 
 9. Gå mer än ett par kilometer 
 10. Gå fler kvarter 
 11. Gå ett kvarter 
 12. Bada/duscha eller klä på dig 
 
Under de senaste 4 veckorna, har du haft något av följande problem med ditt 
arbete eller andra vanliga dagliga aktiviteter på grund av din fysiska hälsa: 
 13. Dragit ner på tiden du ägnat åt arbete eller andra aktiviteter 
 14. Fått mindre gjort än du skulle vilja 
 15. Begränsats i vissa arbetsuppgifter eller andra aktiviteter 
 16. Haft svårt att utföra arbete eller andra aktiviteter 
 
Under de senaste 4 veckorna har du haft något av följande problem med ditt 
arbete eller andra vanliga dagliga aktiviteter på grund av känslomässiga 
problem 
 17. Dragit ner på tiden du ägnat åt arbete eller andra aktiviteter 
 18. Fått mindre gjort än du skulle vilja  
 19. Utfört arbete eller andra aktiviteter mindre noggrant än vanligt 
 20. Under de senaste 4 veckorna, i vilken omfattning har din fysiska 
 hälsa eller känslomässiga problem stört din vanliga sociala aktivitet 
 med familj, släkt, vänner, grannar eller föreningar etc.  
 21. Hur mycket fysisk smärta har du haft under de senaste 4 veckorna 
 22. Under de senaste 4 veckorna, hur mycket har smärta stört ditt 
 vanliga arbete (gäller både arbete utanför hemmet och hushållsarbete) 
 
Följande frågor handlar om hur du känner dig och hur det har varit under de 
senaste 4 veckorna 
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 23. Har du känt dig pigg 
 24. Har du känt dig mycket nervös 
 25. Har du känt dig så nere att ingenting kunnat muntra upp dig 
 26. Har du känt dig lugn och harmonisk 
 27. Har du känt dig energisk 
 28. Har du känt dig dyster och ledsen 
 29. har du känt dig lycklig 
 31. Har du känt dig trött 
 32. Under de senaste 4 veckorna, hur mycket av tiden har din fysiska 
 hälsa eller känslomässiga problem stört dina sociala aktiviteter 
 
Hur väl stämmer följande påståenden in på dig 
 33. Jag verkar ha något lättare att bli sjuk än andra människor 
 34. Jag är lika frisk som andra som jag känner 
 35. Jag tror min hälsa kommer att försämras 
 36. Min hälsa är utmärkt 
 
42. Får vi lov att vid ett senare tillfälle kontakta dig om vi har fler frågor om 
dina erfarenheter av dialysbehandling? 
Är det någonting Du skulle vilja berätta som inte nämnts i enkäten eller något 
Du vill komplettera som tagits upp i enkäten, skriv gärna några rader om det i 
fältet nedan 
 

